Table 3.
Patients with the CD20 expression below the cut-off value
| Histological type of B-cell lymphoma |
Number of patients below the cut-off value/Total number of patients | % of patients below the cut-off value | Number of patients below the cut-off value/Total number of patients | % of patients below the cut-off value | Percentual difference in the proportion of patients below the cut-off value between the two studies |
|---|---|---|---|---|---|
| DLBCL | 11/64 | 17.2 | 6/42 | 14.3 | 2.9 |
| FL | 4/56 | 7.1 | 2/30 | 6.7 | 0.4 |
| CLL | 23/31 | 74.2 | 4/5 | 80.0 | 5.8 |
| MCL | 6/34 | 17.6 | 3/20 | 15.0 | 2.6 |
| MZL | 4/18 | 22.2 | 0/2 | 0 | 22.2 |
| NOS | 5/15 | 33.3 | 5/15 | 33.3 | 0 |
| Total | 53/218 | 24.3 | 20/114 | 17.5 | 6.8 |
DLBCL...diffuse large B-cell lymphoma, FL...follicular lymphoma, CLL chronic lympocytic leukemia, MCL...mantle cell lymphoma, MZL...marginal zone lymphoma, NOS...B- cell lymphoma unclassified, text in bold...the results has been published in our previous study (M. Horvat et al. [8])